Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ziting Zhou

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Angiology|July 28, 2021
Plasma Leukocyte Cell-Derived Chemotaxin 2 (LECT2) as a Risk Factor of Coronary Artery Disease: A Cross-Sectional StudyMengqiu Wei, Jun Liu, Hailin Pan, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|February 27, 2023
To Investigate the Potential Mechanism of Huanglian Jiangtang Formula Lowering Blood Sugar in View of Network Pharmacology and Molecular Docking TechnologyFang Xu Li, Ziting Zhou, Cheng Lu, et al.
Cancer Reports (Hoboken, N.J.)|February 14, 2024
miRNA-449c-5p regulates the JAK-STAT pathway in inhibiting cell proliferation and invasion in human breast cancer cells by targeting ERBB2Li Li, Yangqiurong Zhang, Kunxian Yang, et al.
Asian Journal of Psychiatry|November 17, 2023
The role of microglia in drug addictionHaotian Pan, Jiamin Huang, Ziting Zhou, et al.
European Journal of Medicinal Chemistry|November 6, 2022
Recent advances in gout drugsCheng Shi, Ziting Zhou, Xiaowei Chi, et al.
Journal of the American Chemical Society|September 12, 2025
Immunoglobulin-Directed Phase Separation for Cell-Specific Modulation of Receptor SignalingWeishuai Ren, Peiyuan Zheng, Ziting Zhou, et al.
European Journal of Medical Research|January 4, 2024
Identification and verification of PTPN3 as a novel biomarker in predicting cancer prognosis, immunity, and immunotherapeutic efficacyZiting Zhou, Zhengjun Lin, Mingrui Wang, et al.
Molecular Pharmaceutics|February 19, 2026
Homologous Tumor Cell-Derived Delivery of Doxorubicin via Liquid Nitrogen-Treated 4T1 Cells for Targeted Breast Cancer TherapyFangzhou Yang, Yunqian Lu, Xiaoxue Lang, et al.
Molecular Pharmaceutics|June 1, 2026
Correction to "Homologous Tumor Cell-Derived Delivery of Doxorubicin via Liquid Nitrogen-Treated 4T1 Cells for Targeted Breast Cancer Therapy"Fangzhou Yang, Yunqian Lu, Xiaoxue Lang, et al.
Frontiers in Immunology|June 30, 2023
Ferroptosis-related gene HIC1 in the prediction of the prognosis and immunotherapeutic efficacy with immunological activityYanlin Wu, Zhengjun Lin, Xianzhe Tang, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Angiology|July 28, 2021
Plasma Leukocyte Cell-Derived Chemotaxin 2 (LECT2) as a Risk Factor of Coronary Artery Disease: A Cross-Sectional StudyMengqiu Wei, Jun Liu, Hailin Pan, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|February 27, 2023
To Investigate the Potential Mechanism of Huanglian Jiangtang Formula Lowering Blood Sugar in View of Network Pharmacology and Molecular Docking TechnologyFang Xu Li, Ziting Zhou, Cheng Lu, et al.
Cancer Reports (Hoboken, N.J.)|February 14, 2024
miRNA-449c-5p regulates the JAK-STAT pathway in inhibiting cell proliferation and invasion in human breast cancer cells by targeting ERBB2Li Li, Yangqiurong Zhang, Kunxian Yang, et al.
Asian Journal of Psychiatry|November 17, 2023
The role of microglia in drug addictionHaotian Pan, Jiamin Huang, Ziting Zhou, et al.
European Journal of Medicinal Chemistry|November 6, 2022
Recent advances in gout drugsCheng Shi, Ziting Zhou, Xiaowei Chi, et al.
Journal of the American Chemical Society|September 12, 2025
Immunoglobulin-Directed Phase Separation for Cell-Specific Modulation of Receptor SignalingWeishuai Ren, Peiyuan Zheng, Ziting Zhou, et al.
European Journal of Medical Research|January 4, 2024
Identification and verification of PTPN3 as a novel biomarker in predicting cancer prognosis, immunity, and immunotherapeutic efficacyZiting Zhou, Zhengjun Lin, Mingrui Wang, et al.
Molecular Pharmaceutics|February 19, 2026
Homologous Tumor Cell-Derived Delivery of Doxorubicin via Liquid Nitrogen-Treated 4T1 Cells for Targeted Breast Cancer TherapyFangzhou Yang, Yunqian Lu, Xiaoxue Lang, et al.
Molecular Pharmaceutics|June 1, 2026
Correction to "Homologous Tumor Cell-Derived Delivery of Doxorubicin via Liquid Nitrogen-Treated 4T1 Cells for Targeted Breast Cancer Therapy"Fangzhou Yang, Yunqian Lu, Xiaoxue Lang, et al.
Frontiers in Immunology|June 30, 2023
Ferroptosis-related gene HIC1 in the prediction of the prognosis and immunotherapeutic efficacy with immunological activityYanlin Wu, Zhengjun Lin, Xianzhe Tang, et al.
Pageof 3